Kestra Investment Management LLC Purchases Shares of 998 Chemed Co. (NYSE:CHE)

Kestra Investment Management LLC acquired a new position in Chemed Co. (NYSE:CHEFree Report) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 998 shares of the company’s stock, valued at approximately $600,000.

A number of other institutional investors and hedge funds have also modified their holdings of CHE. SG Americas Securities LLC lifted its position in Chemed by 422.9% during the 2nd quarter. SG Americas Securities LLC now owns 7,551 shares of the company’s stock worth $4,097,000 after acquiring an additional 6,107 shares during the last quarter. Harbor Capital Advisors Inc. boosted its stake in Chemed by 292.7% during the 2nd quarter. Harbor Capital Advisors Inc. now owns 1,241 shares of the company’s stock valued at $673,000 after purchasing an additional 925 shares during the period. Hsbc Holdings PLC grew its holdings in Chemed by 110.0% in the 2nd quarter. Hsbc Holdings PLC now owns 10,638 shares of the company’s stock valued at $5,801,000 after buying an additional 5,572 shares during the last quarter. Evergreen Capital Management LLC bought a new position in Chemed in the 2nd quarter worth approximately $7,812,000. Finally, Quest Partners LLC lifted its holdings in shares of Chemed by 634.3% during the second quarter. Quest Partners LLC now owns 1,990 shares of the company’s stock worth $1,080,000 after buying an additional 1,719 shares during the last quarter. 95.85% of the stock is currently owned by institutional investors and hedge funds.

Chemed Stock Performance

Shares of Chemed stock opened at $572.39 on Monday. Chemed Co. has a twelve month low of $523.33 and a twelve month high of $654.62. The firm has a market cap of $8.61 billion, a P/E ratio of 28.92, a price-to-earnings-growth ratio of 2.43 and a beta of 0.46. The firm’s 50-day simple moving average is $578.27 and its 200-day simple moving average is $565.05.

Chemed (NYSE:CHEGet Free Report) last released its quarterly earnings data on Tuesday, October 29th. The company reported $5.64 earnings per share for the quarter, missing the consensus estimate of $5.76 by ($0.12). The company had revenue of $606.18 million during the quarter, compared to the consensus estimate of $612.22 million. Chemed had a net margin of 12.69% and a return on equity of 27.86%. The company’s revenue for the quarter was up 7.4% on a year-over-year basis. During the same quarter in the prior year, the company posted $5.32 earnings per share. On average, equities analysts forecast that Chemed Co. will post 21.43 earnings per share for the current fiscal year.

Chemed Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 6th. Shareholders of record on Monday, November 18th will be issued a dividend of $0.50 per share. The ex-dividend date of this dividend is Monday, November 18th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.35%. Chemed’s payout ratio is presently 10.11%.

Analyst Upgrades and Downgrades

CHE has been the topic of several research analyst reports. Royal Bank of Canada lowered their price objective on shares of Chemed from $697.00 to $633.00 and set an “outperform” rating on the stock in a research note on Tuesday, November 5th. StockNews.com upgraded shares of Chemed from a “hold” rating to a “buy” rating in a report on Saturday.

Read Our Latest Stock Report on CHE

Insider Activity

In related news, EVP Nicholas Michael Westfall sold 1,713 shares of the stock in a transaction that occurred on Monday, September 9th. The stock was sold at an average price of $569.35, for a total transaction of $975,296.55. Following the sale, the executive vice president now directly owns 6,109 shares in the company, valued at $3,478,159.15. This represents a 21.90 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction on Thursday, September 26th. The shares were sold at an average price of $598.81, for a total value of $1,197,620.00. Following the completion of the transaction, the chief executive officer now owns 103,735 shares of the company’s stock, valued at approximately $62,117,555.35. The trade was a 1.89 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 6,845 shares of company stock worth $3,978,798. Corporate insiders own 3.32% of the company’s stock.

Chemed Company Profile

(Free Report)

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.

Further Reading

Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Co. (NYSE:CHEFree Report).

Institutional Ownership by Quarter for Chemed (NYSE:CHE)

Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.